Workforce6 min read

What a Right to Choose clinical bench actually looks like

Referral volume is not the constraint. Assessor capacity, supervision ratios and reporting turnaround are, and they need to be staffed as one system.

Written by Tyler Denbigh, HealthRec Founder and ExpertReviewed July 2026
Short answer

Most providers entering Right to Choose pathways model demand first and staffing second. That order is backwards. Referrals arrive in weeks; a compliant assessor bench takes months to build, credential and supervise.

What a Right to Choose clinical bench actually looks like | Reviewed July 2026

What Right to Choose actually obliges a provider to do

Right to Choose gives patients in England a legal right to choose their provider for a first outpatient appointment, where the provider holds an NHS standard contract and meets NHS cost and quality requirements. In adult ADHD and ASD assessment that has moved substantial volume out of trust waiting lists and into independent providers.

The obligations that come with it are what shape the workforce. A defined assessment protocol. Reporting turnaround within the SLA in the contract. Data returns. Shared care correspondence with the patient's GP. Clinical audit. Duty of candour. None of that is optional, and all of it lands on the clinical bench rather than on the operations team.

That is why a Right to Choose bench looks different from a private self-pay bench. It is more documented, more standardised, and it needs a supervision structure that can survive being examined.

The three layers a workable bench needs

A workable bench has three layers. A permanent core that owns clinical standards and supervision. A sessional layer that flexes with referral peaks. And a reporting layer, often the forgotten one, that turns completed assessments into letters within the SLA you signed up to.

Permanent core: responsible clinician for the pathway, supervising consultants, clinical lead. Slow to hire, hard to replace, and the part a commissioner examines first.

Sessional assessors: consultant psychiatrists, specialty doctors, clinical psychologists and trained ANPs, engaged per session or per assessment, flexing with referral flow.

Titration and review prescribers: independent prescribers with controlled drugs scope. This caseload compounds rather than flexing, and it is the layer most providers under-forecast.

Reporting and pathway administration: pre-assessment pack assembly, evidence chasing, letter turnaround and GP correspondence. Understaff this and your clinicians absorb it, which is the most expensive way to buy administration.

Supervision ratio is the number that decides everything

The ratio matters more than the headcount. One supervising clinician per six to eight assessors keeps quality defensible under audit. Push past that and you will pass volume targets while quietly accumulating governance risk.

The mistake is treating supervision as a proportion of clinical time that can be squeezed when volume rises. It cannot. When referral volume spikes, supervision demand rises with it, and the supervising consultant is the hardest person in the model to add quickly. Providers who commit to a ratio in advance and hold it are the ones who survive their first audit intact.

Titration is the caseload that never goes down

Assessment produces a diagnosis. Titration produces a patient who needs reviewing for months, and then a stable patient who needs reviewing annually. Assessment demand moves with referral flow. Titration caseload only accumulates.

Model it as a compounding liability from month one, staffed by independent prescribers with documented controlled drugs scope and a named supervision line. Providers who staff assessment properly and titration late end up with a diagnosed population they cannot safely manage, which is a considerably worse position than a waiting list.

Build the supervision layer first

Build the supervision layer before the delivery layer. It is slower to hire, harder to replace, and it is the part a regulator will look at first. Scale Health typically holds supervising capacity against a provider's forecast rather than sourcing it when the contract goes live, because the lead time on a supervising consultant is measured in months and the lead time on a referral is measured in days.

Questions commissioners and clinicians both ask

How long does it take to build a Right to Choose clinical bench?

Assume three to six months for the supervision layer and the responsible clinician, and four to ten weeks for sessional assessors once supervision is in place. Credentialing itself averages ten working days through our portal, but that is the last step, not the constraint. Providers who start recruiting when the contract is signed are already late.

What supervision ratio is defensible for ADHD assessment?

One supervising clinician per six to eight assessors is the working standard we recommend and staff to. Above that, audit sampling rates fall, second-opinion routes get slower, and the supervising clinician's own clinical judgement degrades under volume. It is the first thing to question when a provider's assessment quality starts drifting.

Who can carry out adult ADHD assessments under Right to Choose?

Consultant psychiatrists, specialty doctors, clinical psychologists and suitably trained advanced nurse practitioners, all working within a supervision structure led by a consultant who is the responsible clinician for the pathway. Titration and medication review additionally require independent prescriber status with an appropriate controlled drugs framework.

What does a Right to Choose bench cost to staff?

Indicatively, consultant assessors run £350 to £550 per adult diagnostic assessment including reporting, ANP and specialty doctor assessors £180 to £300 under supervision, titration prescribers £55 to £90 per hour, and supervising clinicians £140 to £190 per hour. The variable that moves total cost most is whether report writing is inside the fee.

Working on this right now?

We build clinical, commercial and leadership teams for regulated health businesses. Tell us the constraint and we will tell you honestly whether we can shift it.

Book a discovery call

More insight

The same benchmarks, market by market, with what is live in each right now.

Related tools and roles